Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Amgen Inc

02 14Novartis Pharmaceuticals Corporation

03 2Novartis South Africa (Pty) Ltd

04 1ORIFARM GROUP AS

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

ERENUMAB-AOOE

Brand Name : AIMOVIG

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 70MG/ML

Packaging :

Approval Date :

Application Number : 761077

Regulatory Info :

Registration Country : USA

blank

02

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Erenumab

Brand Name : Aimovig

Dosage Form : Solution for injection in a pre-filled pen

Dosage Strength : 70 mg/ml

Packaging : Pre-filled pen 1 1ml

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

03

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Erenumab

Brand Name : Aimovig

Dosage Form : Solution for injection in a pre-filled pen

Dosage Strength : 140 mg/ml

Packaging : Pre-filled pen 1 1ml

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

04

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Erenumab

Brand Name : Aimovig

Dosage Form : Solution For Injection

Dosage Strength : 140mg

Packaging :

Approval Date : 26/04/2019

Application Number : 20180731000112

Regulatory Info : Approved

Registration Country : Sweden

blank

05

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Erenumab

Brand Name : Aimovig

Dosage Form : Solution For Injection

Dosage Strength : 140mg

Packaging :

Approval Date : 26/04/2019

Application Number : 20180731000105

Regulatory Info : Approved

Registration Country : Sweden

blank

06

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Erenumab

Brand Name : Aimovig

Dosage Form : Solution For Injection

Dosage Strength : 70mg

Packaging :

Approval Date : 26/07/2018

Application Number : 20170524000047

Regulatory Info : Approved

Registration Country : Sweden

blank

07

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Erenumab

Brand Name : Aimovig

Dosage Form : Solution For Injection

Dosage Strength : 70mg

Packaging :

Approval Date : 26/07/2018

Application Number : 20170524000030

Regulatory Info : Approved

Registration Country : Sweden

blank

08

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Erenumab

Brand Name : Aimovig

Dosage Form : Solution For Injection

Dosage Strength : 70mg/ml

Packaging :

Approval Date : 13/07/2018

Application Number : 66620

Regulatory Info : Allowed

Registration Country : Switzerland

blank

09

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Erenumab

Brand Name : Aimovig

Dosage Form : Solution For Injection

Dosage Strength : 140mg/ml

Packaging :

Approval Date : 13/07/2018

Application Number : 66620

Regulatory Info : Allowed

Registration Country : Switzerland

blank

10

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Erenumab

Brand Name : Aimovig

Dosage Form : Injectable Solution

Dosage Strength : 70mg/ml

Packaging :

Approval Date : 13/07/2018

Application Number : 66748

Regulatory Info : Allowed

Registration Country : Switzerland

blank

11

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Erenumab

Brand Name : Aimovig

Dosage Form : Injectable Solution

Dosage Strength : 140mg/ml

Packaging :

Approval Date : 13/07/2018

Application Number : 66748

Regulatory Info : Allowed

Registration Country : Switzerland

blank

12

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

ERENUMAB

Brand Name : AIMOVIG

Dosage Form : SOLUTION

Dosage Strength : 70MG/ML

Packaging : (1X1 ML) AND (2X1ML)

Approval Date :

Application Number : 2479613

Regulatory Info : Schedule D

Registration Country : Canada

blank

13

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

ERENUMAB

Brand Name : AIMOVIG

Dosage Form : SOLUTION

Dosage Strength : 140MG/ML

Packaging :

Approval Date :

Application Number : 2487306

Regulatory Info : Schedule D

Registration Country : Canada

blank

14

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Erenumab

Brand Name : Aimovig

Dosage Form : Injectable Solution In Pre-Filled Pen

Dosage Strength : 140MG

Packaging :

Approval Date : 2019-06-13

Application Number : 1181293004

Regulatory Info : Authorized

Registration Country : Spain

blank

15

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Erenumab

Brand Name : Aimovig

Dosage Form : Injectable Solution In Pre-Filled Pen

Dosage Strength : 70MG

Packaging :

Approval Date : 2018-08-28

Application Number : 1181293001

Regulatory Info : Authorized

Registration Country : Spain

blank

16

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Erenumab

Brand Name : Aimovig

Dosage Form : Solution for injection in a pre-filled pen

Dosage Strength : 70 mg/ml

Packaging : Pre-filled pen 1 1ml

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

17

Novartis South Africa (Pty) Ltd

Country
The MedTech Conference
Not Confirmed
arrow

Novartis South Africa (Pty) Ltd

Country
arrow
The MedTech Conference
Not Confirmed

Erenumab

Brand Name : Pasurta 70mg/ml

Dosage Form : PFS

Dosage Strength : 70mg/ml

Packaging : 1X1mg/ml

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

blank

18

Novartis South Africa (Pty) Ltd

Country
The MedTech Conference
Not Confirmed
arrow

Novartis South Africa (Pty) Ltd

Country
arrow
The MedTech Conference
Not Confirmed

Erenumab

Brand Name : Pasurta 70mg/ml

Dosage Form : PFS

Dosage Strength : 70mg/ml

Packaging : 1X1mg/ml

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

blank